Gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) are rare diseases
encompassing pancreatic (PanNETs) and ileal NETs (SINETs), characterized by …

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare and heterogeneous
tumors that present a wide spectrum of different clinical and biological characteristics …

Background/Aims: A key issue in neuroendocrine neoplasia management is the
identification of blood signatures that specifically define the activity of a cancer or local tumor …

Abstract Objective Pancreatic neuroendocrine neoplasms (PanNENs) are rare tumors
arising from the endocrine pancreas; however, their prognosis differs significantly upon their …

Abstract Treatment with radiolabelled somatostatin analogs, a form of peptide receptor
radionuclide therapy (PRRT), has changed the management of patients with advanced …

Pancreatic neuroendocrine tumours (PNETs) are relatively uncommon, accounting for 1–2%
of all pancreatic neoplasms. Tumour grade (based on the Ki67 proliferative index and mitotic …

Pancreatic neuroendocrine tumors (PanNETs) are rare tumors; however, their incidence
greatly increases with age, and they occur more frequently among the elderly. They …

In recent years, PET-based molecular imaging has been increasingly used in
neuroendocrine tumors (NETs) for tailoring of treatment strategies on an individual basis …

Background We retrospectively aimed to assess the prognostic significance of somatostatin
receptor (SSTR) standardized uptake value (SUVmaxsstr), SSTR representative tumor …

Abstract Background/Aim: Grading pancreatic neuroendocrine neoplasms (PNENs) via
mitotic rate and Ki-67 index score is complicated by interobserver variability. Differentially …